| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/16/2010 | US20100234299 Stable formulation of modified glp-1 |
| 09/16/2010 | US20100234294 Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof |
| 09/16/2010 | US20100234293 Novel Neurotrophic Factors |
| 09/16/2010 | US20100234291 Preparation and use of low-bleeding anticoagulant fusion protein |
| 09/16/2010 | US20100234290 Stabilized Insulin-like Growth Factor Polypeptides |
| 09/16/2010 | US20100234287 Targeting Bacterial Suicide Pathways for the Development of Novel Antibiotics |
| 09/16/2010 | US20100234283 Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
| 09/16/2010 | US20100234282 System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron |
| 09/16/2010 | US20100234278 Prophylactic and/or therapeutic agents for peripheral neuropathy |
| 09/16/2010 | US20100234272 Processes for Preparing a Polypeptide |
| 09/16/2010 | US20100234246 Method for producing peptide libraries and use thereof |
| 09/16/2010 | US20100233819 Robo: a novel family of polypeptides and nucleic acids |
| 09/16/2010 | US20100233785 Novel methods and interferon deficient substrates for the propagation of viruses |
| 09/16/2010 | US20100233783 Novel method for protein purification |
| 09/16/2010 | US20100233782 Isolated phospholipid-protein particles |
| 09/16/2010 | US20100233781 Tubular nanostructure targeted to cell membrane |
| 09/16/2010 | US20100233780 Methods for Improving Protein Properties |
| 09/16/2010 | US20100233761 Algae biomass fractionation |
| 09/16/2010 | US20100233760 Protein Production in Microorganisms of the Phylum Labyrinthulomycota |
| 09/16/2010 | US20100233758 Protein increasing cell infectivity of herpes simplex virus and use thereof |
| 09/16/2010 | US20100233737 Marker specific to an oxidative degradation of tissues containing type iii collagen, means and methods and kits for the diagnosis, monitoring or prognosis of pathologies targeted by this marker |
| 09/16/2010 | US20100233735 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/16/2010 | US20100233726 Tandem fluorescent protein constructs |
| 09/16/2010 | US20100233718 Non-invasive technique for conducting skin inflammatory disease pharmaco-genomic studies and diagnoses thereof |
| 09/16/2010 | US20100233711 Gene encoding labyrinthin, a marker for cancer |
| 09/16/2010 | US20100233690 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 09/16/2010 | US20100233678 Tunable affinity ligands for the separation and detection of target substances |
| 09/16/2010 | US20100233676 High affinity fluorochrome binding peptides |
| 09/16/2010 | US20100233242 Engineered proteins, and methods of making and using |
| 09/16/2010 | US20100233210 Subgenomic replicons of the flavivirus dengue |
| 09/16/2010 | US20100233199 Modulators of hypersensitivity reactions |
| 09/16/2010 | US20100233191 Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins |
| 09/16/2010 | US20100233189 Crystal structure |
| 09/16/2010 | US20100233186 Novel receptor that binds ctla-8 |
| 09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
| 09/16/2010 | US20100233152 Use of HMGB proteins and nucleic acids that code therefor |
| 09/16/2010 | US20100233146 Coatings and Surface Treatments Having Active Enzymes and Peptides |
| 09/16/2010 | US20100233126 Polypeptide |
| 09/16/2010 | US20100233117 Adjuvant combination formulations |
| 09/16/2010 | US20100233095 Conformationally dynamic peptides |
| 09/16/2010 | US20100233090 Targeting vector-phospholipid conjugates |
| 09/16/2010 | US20100233084 Method for Delivery Across the Blood Brain Barrier |
| 09/16/2010 | CA2787849A1 Injectable biomaterials |
| 09/16/2010 | CA2755300A1 A polynucleotide and polypeptide sequence and methods thereof |
| 09/16/2010 | CA2755109A1 Sparc angiogenic domain and methods of use |
| 09/16/2010 | CA2754945A1 Biological materials and uses thereof |
| 09/16/2010 | CA2754862A1 Anti-cd40 antibodies and uses thereof |
| 09/16/2010 | CA2754056A1 Mirac proteins |
| 09/16/2010 | CA2753883A1 A pkn3/rhoc macromolecular complex and methods of use therefor |
| 09/16/2010 | CA2751301A1 Optimized early-late promoter combined with repeated vaccination favors cytotoxic t cell response against antigens in replication deficient recombinant virus vaccines |
| 09/15/2010 | EP2228448A1 MU-1 member of the cytokine receptor family |
| 09/15/2010 | EP2228447A2 Cloning and characterizing of genes associated with long-term memory |
| 09/15/2010 | EP2228446A1 Secreted and transmembrane polypeptieds and nucleic acids encoding the same |
| 09/15/2010 | EP2228445A1 Fucose Transporter |
| 09/15/2010 | EP2228443A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 09/15/2010 | EP2228440A1 Variants of beta-glucosidases |
| 09/15/2010 | EP2228390A1 Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| 09/15/2010 | EP2228389A2 Antibodies against vascular endothelial growth factor 2 |
| 09/15/2010 | EP2228388A1 Protected Arg-Glu-Arg polypeptides and uses thereof |
| 09/15/2010 | EP2228387A2 Polypeptides derived from amyloid precursor peptide (app) and their uses |
| 09/15/2010 | EP2228386A1 Plants having enhanced yield-related traits and a method for making the same |
| 09/15/2010 | EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228383A1 Library of toxin mutants, and methods of using same |
| 09/15/2010 | EP2228381A2 Alpha-MSH antagonist dipeptide conjugates |
| 09/15/2010 | EP2228379A1 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 09/15/2010 | EP2228075A1 Ionic complex nanoparticles for detecting heparanase activities and method for preparing the same |
| 09/15/2010 | EP2228072A1 Cancer vaccine composition |
| 09/15/2010 | EP2227549A1 Organic compounds |
| 09/15/2010 | EP2227488A1 Fviii peptides and their use in tolerising haemophiliacs |
| 09/15/2010 | EP2227487A1 Ddr1-mediated cell purification of pancreatic endocrine cells through their progenitors |
| 09/15/2010 | EP2227486A1 Peptide analogues and conjugates thereof |
| 09/15/2010 | EP2227485A2 Resistance gene and uses thereof |
| 09/15/2010 | EP2227484A1 Thuricin cd, an antimicrobial for specifically targeting clostridium difficile |
| 09/15/2010 | EP2227483A1 Soluble forms of hendra and nipah virus f glycoprotein and uses thereof |
| 09/15/2010 | EP2227253A1 Vaccine comprising monocyte or immature myeloid cells(imc) which were loaded with the ligand of natural killer t cell and antigen |
| 09/15/2010 | EP2227249A1 Improved immunizing composition |
| 09/15/2010 | EP2227242A2 Bone morphogenic protein binding peptide |
| 09/15/2010 | EP1931697B1 Il-17a and il-17f antagonists and methods of using the same |
| 09/15/2010 | EP1673387B1 Il-21 derivatives |
| 09/15/2010 | EP1543838B1 Feline infectious peritonitis vaccine |
| 09/15/2010 | EP1450857B1 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 09/15/2010 | EP1354196B1 Diagnostics, drug screening and treatment for cancer |
| 09/15/2010 | EP1309617B1 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof |
| 09/15/2010 | EP1250055B1 Immune modulation with death receptor-induced apoptosis |
| 09/15/2010 | EP1026949B1 Outer membrane proteins of ehrlichia chaffeensis |
| 09/15/2010 | CN1752211B Recombination target fused protein for treating acquired immunodeficiency syndrome |
| 09/15/2010 | CN101836115A Use of tenascin-W as a biomarker for colon cancer |
| 09/15/2010 | CN101835897A Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin |
| 09/15/2010 | CN101835801A Transferrin variants and conjugates |
| 09/15/2010 | CN101835800A SDF-1-based glycosaminoglycan antagonists and methods of using same |
| 09/15/2010 | CN101835799A Modulators of hypersensitivity reactions |
| 09/15/2010 | CN101835798A Methods and compositions for targeting proteins of interest to the host cell envelope |
| 09/15/2010 | CN101835796A Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus |
| 09/15/2010 | CN101835795A New antiviral peptides prom african swine fever virus which prevent the binding of the virus to DLC8 |
| 09/15/2010 | CN101835794A Insulinotropic peptide synthesis using solid and solution phase combination techniques |
| 09/15/2010 | CN101835793A Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies |
| 09/15/2010 | CN101835487A Composition and methods of making and using influenza proteins |
| 09/15/2010 | CN101833002A Antibody indirect immunofluorescence test method for distinguishing immune animal infected with influenza A virus |
| 09/15/2010 | CN101831455A Yeast expression system for expressing glycosylated interferon and method for preparing recombinant glycosylated interferon |